Researchers at Virginia Tech have developed a new artificial intelligence tool, RNAbpFlow, capable of predicting 3D RNA structures without relying on evolutionary data or homologous templates. In blind testing, the model produced a correct overall structure for 12 of 14 RNA targets, compared with eight out of 14 for AlphaFold 3, according to research published … Read more
New research led by Niigata University indicates that the risk of Alzheimer’s disease associated with carrying two copies of the APOE4 gene variant is lower in Japanese populations than previously estimated. A meta-analysis published in the journal Molecular Neurodegeneration suggests that Japanese APOE4 homozygotes face a 12–15-fold increased risk of developing the disease, lower than … Read more
Women diagnosed with Parkinson’s disease exhibit a higher amyloid plaque burden in the brain compared to men, according to a study led by the Mayo Clinic Arizona. While men with Parkinson’s are generally at a higher risk of developing dementia, this new research indicates that women harbor more Alzheimer’s-related protein deposits, even when adjusting for … Read more
Researchers at the RCSI University of Medicine and Health Sciences have developed a novel mRNA vaccine for neuroblastoma using self-assembling peptide nanoparticles. According to study lead Olga Piskareva, the vaccine, which targets the glypican 2 (GPC2) antigen, reduced tumor volume by 70% in murine models. This approach offers a potential alternative to traditional lipid-based delivery … Read more
Researchers at the Broad Institute of MIT and Harvard have developed a deep learning model capable of identifying novel antibiotic candidates to combat drug-resistant gonorrhea. Published in Science Translational Medicine, the study reveals that a graph neural network (GNN) successfully identified two compounds, MP20 and A1, which kill Neisseria gonorrhoeae through mechanisms distinct from current … Read more
Researchers at the University of Barcelona have identified that tumor-associated fibroblasts (TAFs) act as primary regulators of blood vessel formation in non-small cell lung cancer (NSCLC), explaining why lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) respond differently to anti-angiogenic therapies. Published in Cell Death & Disease, the study shows that fibroblast-driven differences in oxygen … Read more
Researchers at Radboud University Medical Center have developed a long-read genome sequencing test capable of replacing 15 standard genetic diagnostics with a single analysis. According to a study published in the New England Journal of Medicine, this technology identifies complex mutations and epigenetic modifications that conventional short-read sequencing often misses, potentially accelerating diagnosis for the … Read more
Tune Therapeutics has reported early clinical evidence that its epigenetic silencing technology can durably suppress the hepatitis B virus (HBV) in humans by targeting the virus’s “molecular reservoir,” according to data presented at the European Association for the Study of Liver (EASL) Congress. By modulating gene expression without permanently editing DNA, the therapy, TUNE-401, aims … Read more
Unlocking the Genetic Blueprint: The Future of Alzheimer’s Prevention For decades, the search for an Alzheimer’s “cure” has felt like navigating a labyrinth in the dark. While the APOE ε4 gene has long been our primary beacon, a massive, unprecedented genetic study has finally turned on the lights. By analyzing nearly one million individuals, researchers … Read more
The Future of Alzheimer’s: Shifting from Late-Stage Reaction to Early Detection For decades, Alzheimer’s disease has been characterized as a diagnosis that arrives only after major symptoms manifest. However, the medical landscape is undergoing a paradigm shift. With new research published in The Lancet, the focus is moving toward detecting the disease years—or even decades—before … Read more